Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density.

Tumor growth is angiogenesis dependent. As a consequence, strategies aimed at disrupting this mechanism are heavily investigated. Several angiogenesis assays are used to directly compare the efficacy of anti-angiogenic compounds. However, objective assessment of new vascular growth has been difficult to achieve. The aim of this study was to test and develop a computer-assisted image analysis method that would give an unbiased quantification of the microvessel density. Human tumors were grown in athymic mice and tumor biopsies were taken after a weeklong treatment with VEGF-toxin conjugate. Frozen tumor sections were prepared and stained with PE-conjugated anti-CD-31 antibodies and vessels were imaged with a fluorescence microscope. Vessel density was analyzed by quantifying PE-positive pixels per recorded field. In addition, images were further processed to investigate morphological differences by an automated binarization and skeletonization protocol. This procedure allowed the computer-assisted estimation of important angiogenic parameters such as total vessel number, length, and branch points. Based on these indices, differences in the angiogenic response between control tumors and those treated with VEGF-toxin conjugate were readily detected (P < 0.007 for all parameters). More importantly, computer-generated measurements correlated well with manual microvessel counts and showed significantly less variation. Our results suggest that computer-assisted image analysis represents a rapid, objective, and alternative method for the quantitative assessment of tumor angiogenesis and vessel architecture.

[1]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[2]  B. Delahunt,et al.  Microvessel density as a prognostic marker for transitional cell carcinoma of the bladder. , 1998, British journal of urology.

[3]  Alan S. Perelson,et al.  Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.

[4]  N. Kinukawa,et al.  Prognostic significance of epithelial-stromal vascular cuffing and microvessel density in squamous cell carcinoma of the uterine cervix. , 1999, Gynecologic oncology.

[5]  Sabita Roy,et al.  Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor‐toxin conjugate , 1997, International journal of cancer.

[6]  A. Griffioen,et al.  Rocking the foundations of solid tumor growth by attacking the tumor's blood supply. , 1998, Immunology today.

[7]  S. Schmidt,et al.  Quantitation of angiogenesis in the chick chorioallantoic membrane model using fractal analysis. , 1996, Microvascular research.

[8]  G. Groenewegen,et al.  Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. , 1996, Cancer research.

[9]  D. Bostwick,et al.  Microvessel density in renal cell carcinoma: lack of prognostic significance. , 1995, Urology.

[10]  M. Tsuneyoshi,et al.  Angiogenesis does not correlate with prognosis or expression of vascular endothelial growth factor in synovial sarcomas. , 1999, Oncology reports.

[11]  Rakesh K. Jain,et al.  Quantitative angiogenesis assays: Progress and problems , 1997, Nature Medicine.

[12]  P. Marsden,et al.  Vascular endothelial platelet endothelial adhesion molecule-1 (PECAM-1) expression is decreased by TNF-alpha and IFN-gamma. Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. , 1996, Journal of immunology.

[13]  D. Mohanraj,et al.  Expression and radiolabeling of recombinant proteins containing a phosphorylation motif. , 1996, Protein expression and purification.

[14]  Zeng-chen Ma,et al.  Microvessel density of hepatocellular carcinoma: its relationship with prognosis , 1999, Journal of Cancer Research and Clinical Oncology.

[15]  S. Fox,et al.  Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. , 1996, European journal of cancer.

[16]  L. Akslen,et al.  Angiogenesis is prognostically important in vertical growth phase melanomas. , 1999, International journal of oncology.

[17]  J. Folkman,et al.  Angiogenesis and angiogenesis inhibition: an overview. , 1997, EXS.

[18]  S. Kyriacos,et al.  Dynamic study of the extraembryonic vascular network of the chick embryo by fractal analysis. , 1998, Journal of theoretical biology.

[19]  R. Jain,et al.  Delivery of molecular and cellular medicine to solid tumors. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[20]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[21]  M. Janicek,et al.  Tumor angiogenesis as a prognostic factor in ovarian carcinoma , 1997, Cancer.

[22]  J. Dixon,et al.  Reproducibility of microvessel counts in breast cancer specimens , 1999, British Journal of Cancer.

[23]  A. Kaider,et al.  Prognostic significance of tumor angiogenesis in epithelial ovarian cancer. , 1999, Cancer letters.

[24]  J. Sun,et al.  IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. , 1995, Journal of immunology.

[25]  J. Arends,et al.  Microvessel density in unknown primary tumors , 1997, International journal of cancer.

[26]  J. Dimopoulos,et al.  Quantitative assessment of angiogenesis in the chick embryo and its chorioallantoic membrane by computerised analysis of angiographic images. , 1999, European journal of radiology.

[27]  D. Mohanraj,et al.  Expression of biologically active human vascular endothelial growth factor in yeast. , 1995, Growth Factors.

[28]  B. Geiger,et al.  Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells , 1994, The Journal of cell biology.

[29]  J. Folkman,et al.  Tumoral vascularity as a prognostic factor in cancer. , 1996, Important advances in oncology.

[30]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[31]  M J Rieder,et al.  A computerized method for determination of microvascular density. , 1995, Microvascular research.

[32]  A. Griffioen Phenotype of the tumor vasculature; cell adhesion as a target for tumor therapy , 1997 .

[33]  P. Parsons-Wingerter,et al.  A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. , 1998, Microvascular research.

[34]  V. Bautch,et al.  Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. , 1996, Cancer research.

[35]  R Weissleder,et al.  Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis. , 1998, Microvascular research.

[36]  K. Okada,et al.  Quantification of tumour‐induced angiogenesis by image analysis , 1996, International journal of experimental pathology.